Geneva, 20 September 2023 – As the United Nations General Assembly convenes world leaders at the High-Level Meeting on Tuberculosis (TB) this week, discussions will focus on the urgent need for access and innovation to put an end to a disease that we have known how to cure for decades. Despite this, TB continues to kill more people each year than any other infectious disease.

Ukraine, Belarus, Azerbaijan and Moldova demand that Johnson & Johnson take urgent action to improve equitable access to bedaquiline in all countries with a high burden of TB.

The World Health Organization (WHO) provided the latest logistical information regarding the upcoming UN High-Level Meeting on TB to be held on 22 September 2023 in New York City. It can be accessed here together with various advocacy materials.

A sobering new analysis from Treatment Action Group shows that governments failed to meet previous commitments to fund TB research.

Ahead of the UN General Assembly High-Level Meeting on TB, the 1/4/6×24 Campaign is sounding the alarm that the political declaration commits neither the funding nor the actions needed to expand access to the best-available TB regimens and diagnostics.

Global Fund, Stop TB Partnership and USAID announce new collaboration with Danaher to reduce price and increase access to Cepheid’s TB test. Five million additional tests can be procured with this lower price.

On 19 September 2023, the Stop TB Partnership launched its Coalition of leaders against TB initiative which is meant to lead global efforts to end TB at an event at United Nations Headquarters. The launch came at the start of the UN General Assembly high-level week.

DALLAS (SMU), September 19, 2023 – Southern Methodist University (SMU) chemistry professor John Buynak and his team have received a $3.5 million, 5-year grant from the National Institutes of Health to design and synthesize new antibiotics to fight some of the deadliest and most clinically challenging infections of the 21st century – drug resistant strains of bacteria that cause tuberculosis and leprosy.

The World Health Organization 2022 Africa regional report underestimated the incidence rate of tuberculosis in sub-Saharan African individuals living with HIV, according to a recent analysis.

Results in the fight against HIV, TB and malaria exceed pre-COVID-19 numbers; yet colliding crises keep the world way off track to achieve 2030 targets.